Green Thumb Industries (GTBIF) Net Cash Flow (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Net Cash Flow came in at $60.9 million in Q1 2026, up 56.65% YoY from $38.9 million in Q1 2025, and up 22.18% on a QoQ basis from $49.9 million in Q4 2025.
Green Thumb Industries (GTBIF) Net Cash Flow (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Net Cash Flow data on file, last reported at $60.9 million in Q1 2026.
- Quarterly Net Cash Flow rose 56.65% year-over-year to $60.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.6 million (up 1115.57% YoY) and the FY2025 annual result came in at $113.6 million, up 1029.96% from the prior year.
- Net Cash Flow grew to $60.9 million in Q1 2026, from $49.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $62.3 million in Q1 2024 to a low of -$55.9 million in Q1 2022.
- A 5-year average of $6.8 million and a median of $2.0 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow tumbled 715.04% — and 2025, when it soared 2652.15%.
- Tracing GTBIF's Net Cash Flow over 5 years: stood at $30.4 million in 2022, then declined by 18.51% to $24.8 million in 2023, then plunged by 107.88% to -$2.0 million in 2024, then soared by 2652.15% to $49.9 million in 2025, then grew by 22.18% to $60.9 million in 2026.
- The last three Net Cash Flow figures came in at $60.9 million (Q1 2026), $49.9 million (Q4 2025), and $58.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -62.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -62.63 Mn |
| Jun 30, 2026 | -62.63 Mn |
| Mar 31, 2026 | 60.93 Mn |
| Mar 31, 2026 | 60.93 Mn |
| Dec 31, 2025 | 49.87 Mn |
| Dec 31, 2025 | 49.87 Mn |
| Sep 30, 2025 | 58.49 Mn |
| Sep 30, 2025 | 58.49 Mn |
| Jun 30, 2025 | -33.66 Mn |
| Jun 30, 2025 | -33.66 Mn |
| Mar 31, 2025 | 38.90 Mn |
| Mar 31, 2025 | 38.90 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -22.50 Mn |
| Sep 30, 2024 | -22.50 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Mar 31, 2024 | 62.30 Mn |
| Mar 31, 2024 | 62.30 Mn |